Snowball logo
logo
NXG

NexgenRX Inc.

NXG โ€ข V
CA$0.56+CA$0.01ย  (1.82%)
Estimate
P/E
28
EPS
0.02
Beta
0.515
Growth
Revenue, YoY
11.62%
Net income, YoY
132.98%
FCF, YoY
-84.72%
Dividends
Div. yield, TTM
1.79%
Annual payout, TTM
CA$0.01
Payout
65.19%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
NXG
ISIN
CA65337X1042
Country
Canada
Sector (GICS)
Healthcare
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Frequently asked questions

What sector does NexgenRX Inc. (NXG) operate in?

NexgenRX Inc. belongs to the Healthcare sector and operates in the Health Information Services industry.

What is NexgenRX Inc. (NXG) current stock price?

As of the latest data, NexgenRX Inc. stock price is CA$0.56, with a previous close of CA$0.55. NexgenRX Inc. gained CA$0.01 in the last trading session, representing a 1.82% increase.

What is NexgenRX Inc. (NXG) current market capitalization?

NexgenRX Inc. market cap is approximately 39.83 million.

What is NexgenRX Inc. (NXG) Earnings Per Share (EPS)?

The trailing EPS is CA$0.02.

What is NexgenRX Inc. (NXG) Price-to-Earnings (P/E) ratio?

NexgenRX Inc. current P/E ratio is 28.

Does NexgenRX Inc. (NXG) pay dividends?

Yes. NexgenRX Inc. pays semiannual dividends with an annualized yield of 1.79% and an estimated annual payout of CA$0.01 per share.

When is NexgenRX Inc. (NXG) next earnings report?

NexgenRX Inc. is expected to release its next earnings report on June 30, 2026.

What is NexgenRX Inc. (NXG) beta (volatility) score?

NexgenRX Inc. has a beta of 0.515, indicating lower volatility than the overall market.